|
Re: Don's latest presentation
|
1
|
Resverlogix Corp.
|
Sep 22, 2020 01:01PM
|
|
Re: OTC- ZHCLF -TFSA
|
1
|
Zenith Epigenetics
|
Dec 14, 2020 01:50PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 01:21PM
|
|
Re: Financing
|
1
|
Resverlogix Corp.
|
Feb 04, 2021 01:54PM
|
|
Re: TLD Confidence
|
1
|
Resverlogix Corp.
|
Aug 27, 2019 02:54PM
|
|
Re: A new day for RVX
|
1
|
Resverlogix Corp.
|
May 13, 2021 09:52AM
|
|
Re: The chart set up looks awesome imo....
|
1
|
Resverlogix Corp.
|
Dec 03, 2019 04:12PM
|
|
Re: MD&A
|
1
|
Resverlogix Corp.
|
Sep 14, 2020 12:13PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
1
|
Resverlogix Corp.
|
May 09, 2022 09:26AM
|
|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving HF - simple suggestion
|
1
|
Resverlogix Corp.
|
Jan 13, 2021 05:47PM
|
|
Re: According to the TMX website there are only 5 million RVX.WT.A oustanding....
|
1
|
Resverlogix Corp.
|
Jun 20, 2019 07:42PM
|
|
Re: Contradictory short interest data for OTC RVXCF
|
1
|
Resverlogix Corp.
|
Aug 08, 2019 06:57AM
|
|
Re: USA ZHCLF investors
|
1
|
Zenith Epigenetics
|
Nov 01, 2022 09:23AM
|
|
Re: Abstract up
|
1
|
Resverlogix Corp.
|
Mar 17, 2020 08:05PM
|
|
Re: DM conflict of interest
|
1
|
Resverlogix Corp.
|
Nov 09, 2023 01:34PM
|
|
Re: 2 year extension
|
1
|
Resverlogix Corp.
|
May 14, 2024 03:35PM
|
|
BIOAF
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 25, 2022 03:10PM
|
|
Re: Update
|
1
|
Resverlogix Corp.
|
Jun 12, 2019 09:56AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 09:07AM
|
|
Re: Hepa...
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 05:06PM
|
